DEAR VISITORS, THE NEW WEBSITE IS UNDER CONSTRUCTION, SO WE ASK FOR YOUR UNDERSTANDING IF YOU ENCOUNTER OUT-OF-DATE OR INCORRECT INFORMATION. FOR ALL QUESTIONS, WE ARE AT YOUR DISPOSAL BY PHONE +38131597597 or e-mail address: office@cigota.rs
Srpski
English
Русский
Neglected aspect of WHI study
English
School of Medicine, University of Belgrade, Clinic for Endocrinology, Diabetes and Metabolic diseases Clinical Center of Serbia
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 2002;
Naftolin F, Taylor HS, Karas R, Brinton E, Newman I, Clarkson TB et al. The Women’s Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition. Fertil Steril 2004; 81(6):1498-1501.
Naftolin F, Schneider HPG, Sturdee DW, Birkhauser.M., Gambacciani M, Limpaphayom KK et al. Guidelines for hormone treatment of women in the menopausal transition and beyond. Climacteric 2004; 7(4):333-337
Neglected aspect of WHI study
| Attachment | Size |
|---|---|
 milos_e.pdf | 532.98 KB |
CONTACT US